The diagnostics company Myriad Genetics introduces a DNA test that could reveal a woman’s risk even if she doesn’t have one of the gene variants now associated with the disease

Quick Read

Trust in different guidelines and a physician’s specialization affect their screening recommendations, according to the study published in the Journal of the American Medical Association Internal Medicine

Quick Read

Three years ago, Angelina Jolie announced in a New York Times op-ed that she’d had a preventive double mastectomy after testing positive for mutations in the BRCA1 gene, which put her at an increased risk of breast and ovarian cancers

Quick Read

Before Debbie Bowers had surgery for breast cancer, her doctor promised that insurance would pay for reconstruction, and said she could “even go up a cup size.” But Ms. Bowers did not want a silicone implant or bigger breasts. “Having something foreign in my body after a cancer diagnosis is the last thing I wanted,” said Ms. Bowers, 45, of Bethlehem, Pa. “I just wanted to heal.”

Quick Read

As many as 60,000 American women each year are told they have a very early stage of breast cancer — Stage 0, as it is commonly known — a possible precursor to what could be a deadly tumor. And almost every one of the women has either a lumpectomy or a mastectomy, and often a double mastectomy, removing a healthy breast as well

Quick Read